![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, January 09, 2019 2:24:51 PM
We look forward to welcoming a new
director to the Board – Dr Claudia Süssmuth
Dyckerhoff PhD – who has extensive global
healthcare experience across Europe, Asia
and the USA. Dr Süssmuth Dyckerhoff is
an external senior advisor with McKinsey
& Company, and has led McKinsey’s Asia
wide Health Systems and Services Sector
where she supported healthcare companies
as well as governments after transferring
to China. She is a director on the boards of
Hoffmann La Roche, Clariant and the med
tech start-up Cyrcadia. Her experience in
healthcare strategy, privatisation of assets
in the health services arena, organisational
redesign, capability building and operational
performance improvement in hospitals, will
be a great addition to the Ramsay Board and
we look forward to her commencement as
a director.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM